Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
Learn more: NUS scientists develop novel chip for fast and accurate disease detection at low cost
The Latest on: Disease detection
[google_news title=”” keyword=”disease detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Disease detection
- Health Ministry Launches Early Detection and Treatment Campaign Against Liver Canceron April 28, 2024 at 9:07 am
AstraZeneca Egypt has announced its collaboration with the Ministry of Health and Population to inaugurate a campaign focused on the early detection and treatment of hepatocellular carcinoma (HCC), ...
- AstraZeneca Egypt and MoHP launch early detection and treatment campaign against liver canceron April 27, 2024 at 5:00 pm
Furthermore, it introduces cutting-edge international methodologies for early diagnosis and detection of liver diseases, particularly liver cancer, aiming to enhance patient response rates to ...
- Chronic wasting disease detected in Edwards County deer breeding facilityon April 25, 2024 at 11:24 am
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
- Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious diseaseon April 25, 2024 at 8:52 am
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda ...
- Fatal ‘zombie deer’ disease found in Harpers Ferry National Historical Parkon April 24, 2024 at 12:20 pm
Two white-tailed deer inside Harpers Ferry National Historical Park in West Virginia have tested positive for the fatal Chronic Wasting Disease.
- Company developing early cancer-detection tests to cut 20% of workforceon April 24, 2024 at 7:35 am
Early cancer-detection test maker that raised $254 million earlier this year now says it will cut more than 100 jobs — about 20% of its workforce — as it restructures ...
- 2024 Report | European Biopsy Devices Market to Reach US$ 1,074.0 Million by 2032: Enhanced Focus on Early Disease Detection Fuels Growthon April 24, 2024 at 6:41 am
It is projected to grow at a CAGR of 5.99% from 2024 to 2032. The analyst forecasts it to reach US$ 1,074.0 Million by 2032. The increasing emphasi ...
- Researchers aim to use AI for early screening and prognosis of Dry Eye Diseaseon April 23, 2024 at 1:19 pm
Dry Eye Disease (DED) is one of the more common eye diseases, affecting up to 30% of the world's population. This disease can affect many different types of people and can wind up being a great ...
- Artificial intelligence to be used for the detection of common eye diseaseon April 23, 2024 at 6:14 am
Here is where the combined efforts of ophthalmic disease detection and the world of computer scientists and engineers can help. “By addressing challenges, imparting insights, and delineating future ...
via Bing News